Glycemic control and high-density lipoprotein characteristics in adolescents with type 1 diabetes

Pediatric Diabetes

Volumn 14, Issue 6, 2013, Pages 399-406

  Medina Bravo, Patricia ^a   Medina Urrutia, Aída ^b   Juárez Rojas, Juan Gabriel ^b   Cardoso Saldaña, Guillermo ^b   Jorge Galarza, Esteban ^b   Posadas Sánchez, Rosalinda ^b   Coyote Estrada, Ninel ^a   Nishimura Meguro, Elisa ^c   Posadas Romero, Carlos ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Adhesion molecules; Adolescents; Cholesterol efflux; Glycemic control; HDL subclasses; Type 1 diabetes

Indexed keywords

CHOLESTEROL ESTER; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHEMICAL COMPOSITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADHESION MOLECULES; ADOLESCENTS; CHOLESTEROL EFFLUX; GLYCEMIC CONTROL; HDL SUBCLASSES; TYPE 1 DIABETES;

ADOLESCENT; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CHILD; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; MALE; RATS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84882660625     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00924.x     Document Type: Article

References (36)

1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetiologia 2001: 44: S14-S21.
2. Soedamah-Muthu SS, Chaturvedi N, Toeller M et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe. Diabetes Care 2004: 27: 530-537.
3. Guy J, Ogden L, Wadwa P et al. Lipid and lipoprotein profiles in youth with and without type 1 diabetes. Diabetes Care 2009: 32: 416-420.
4. Petitti DB, Imperatore G, Palla SL et al. Serum lipids and glucose control: The SEARCH for Diabetes in Youth Study. Arch Pediatr Adolesc Med 2007: 161: 159-165.
5. Nordwall M, Aenqvist H, Bojesting M, Ludvigsson J. Good glycemic control remains crucial in prevention of late diabetic complications-the Linköping Diabetes Complications Study. Pediatr Diabetes 2009: 10: 168-176.
6. Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am J Cardiol 2000: 86: 19-22.
7. Asztalos BF, Collins D, Cupples LA et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial. Arterioscler Thromb Vasc Biol 2005: 25: 2185-2191.
8. De la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Cuchel M, Rader DJ, Rothblat GH. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler ThrombVac Biol 2010: 30: 796-801.
9. Williams PT, Krauss RM, Nichols AV, Vranizan KM, Wood PD. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 1990: 31: 1131-1139.
10. Chahil TJ, Ginsberg HN. Diabetic dyslipidemia. Endocrinol Metab Clin North Am 2006: 35: 491-510.
11. Vergeer M, Holleboom AG, Kastelein JJ, Kuivenhoven JA. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 2010: 51: 2058-2073.
12. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004: 95: 764-772.
13. Yancey PG, Bortnick AE, Kellner-Weibel G, De la Llera-Moya M, Phillips MC, Rothblat GH. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003: 23: 712-719.
14. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002: 51: 1949-1956.
15. Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ, Pittsburgh Epidemiology of Diabetes Complications Study. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2003: 46: 674-682.
16. Gallo LM, Silverstein JH, Shuster JJ, Haller MJ. Arterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetes. J Pediatr Endocrinol Metab 2010: 23: 661-667.
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012: 35: S64-S71.
18. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969: 44: 291-303.
19. Delong DM, Delong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986: 256: 2372-2377.
20. Pérusse M, Pascot A, Després JP, Couillard C, Lamarche B. A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. J Lipid Res 2001: 42: 1331-1334.
21. Blanche PJ, Gong EL, Forte TM, Nichols AV. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981: 665: 408-419.
22. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 1981: 22: 339-358.
23. Guerin M, Lassel TS, le Goff W, Farnier M, Chapman MJ. Action of atorvastatin in combined hyperlipidemia :preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscler Thromb Vasc Biol 2000: 20: 189-197.
24. Asztalos BF, Roheim PS, Milani RL et al. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000: 20: 2670-2676.
25. De la Llera Moya M, Atger V, Paul JL et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb Vasc Biol 1994: 14: 1056-1065.
26. Valabhji J, Mccoll AJ, Schachter M, Dhanjil S, Richmond W, Elkeles RS. High-density lipoprotein composition and paraoxonase activity in type 1 diabetes. Clin Sci 2001: 101: 659-670.
27. Jenkins AJ, Lyons TJ, Zheng D et al. Serum lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort. Diabetes Care 2003: 26: 810-818.
28. Bagdade JD, Buchanan WE, Levy RA, Subbaiah PV, Ritter MC. Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes 1990: 39: 426-431.
29. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991: 21: 161-167.
30. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002: 105: 1135-1143.
31. Seckin D, Ilhan N, Ilhan N, Ertugrul S. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diabetes Res Clin Pract 2006: 73: 191-197.
32. Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 2005: 54: 1020-1026.
33. Maggio AB, Farpour-Lambert NJ, Montecucco F et al. Elevated E-selectin and diastolic blood pressure in diabetic children. Eur J Clin Invest 2012: 42: 303-309.
34. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007: 4: 84-88.
35. De Vries R, Kerstens MN, Sluiter WJ, Groen AK, Van Tol A, Dullaart RP. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment. Diabetologia 2005: 48: 1105-1113.
36. Fournier N, Paul JL, Atger V et al. HDL Phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997: 17: 2685-2691.